4/A//SEC Filing
BLAISE LUCILE 4/A
Accession 0001127602-22-026089
CIK 0000943819other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 7:18 PM ET
Size
6.9 KB
Accession
0001127602-22-026089
Insider Transaction Report
Form 4/AAmended
RESMED INCRMD
BLAISE LUCILE
President, Sleep & RC Business
Transactions
- Tax Payment
ResMed Common Stock
2022-11-15$225.18/sh−169$38,055→ 6,819 total - Award
ResMed Common Stock Options
2022-11-16$224.58/sh+2,410$541,238→ 2,410 totalExercise: $224.58From: 2023-11-11Exp: 2029-11-16→ ResMed Common Stock (2,410 underlying)
Footnotes (3)
- [F1]Corrects transaction as disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/14/2018.
- [F2]Reflects corrected share beneficially owned.
- [F3]Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2023, 2024 and 2025.
Documents
Issuer
RESMED INC
CIK 0000943819
Entity typeother
Related Parties
1- filerCIK 0001938112
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 7:18 PM ET
- Size
- 6.9 KB